Stockreport

Cerus Corporation Announces Five-Year FDA Contract for the Development of Next Generation Pathogen Reduction Technology to Treat Whole Blood

Cerus Corporation  (CERS) 
Last cerus corporation earnings: 2/20 04:01 pm Check Earnings Report
PDF CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq:CERS) announced today it was awarded a five-year contract with the U.S. Food and Drug Administration (FDA [Read more]